The latest news:

• GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy (Correction)         Correction - I sent this out in the last news blast but my comments were incorrect.  I said it adds 10 months to the progression free survival time, which is the number for all types of brain tumors, not just GBM.  For GBM it is 4 months, which is still very good.  For metastatic tumors and meningiomas it is a lot more!
  

BrainTumor Co-Payment Assistance Program Status:

• Almost closed to new applicants - Call first